Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1527-1531 , December 1995

Identification of galactitol 2-phosphate and galactitol 3-phosphate in the lens of galactose-fed rats

Received 1 July 1994 ,Accepted 4 May 1995.

References 

  1. Kinoshita JH. A thirty year journey in the polyol pathway. Exp Eye Res. 1990;50:567–573
  2. Kinoshita JH, Datiles MB, Kador PF, et al.  Aldose reductase and diabetic eye complications. In: ed 3.  Rifkin H,  Porte D editor. Diabetes Mellitus. New York, NY: Elsevier; 1990;p. 264–278
  3. Kador P. The role of aldose reductase in the development of ocular diabetic complications. In:  Drazin B,  Melmed S,  Leroith D editor. Complications of Diabetes Mellitus. New York, NY: Liss; 1989;p. 103–114
  4. Belpoiti M, Maraini G. Sugar alcohols in the lens epithelium of age related cataract. Exp Eye Res. 1993;56:3–6
  5. Dyer DG, Blackledge JA, Thorpe SR, et al.  Formation of pentosidine during nonenzymatic browning of proteins by glucose. J Biol Chem. 1991;266:11654–11660
  6. Swamy MS, Tsai C, Abraham A, et al.  Glycation mediated lens crystallin aggregation and cross linking by various sugars and sugar phosphates in vitro. Exp Eye Res. 1993;56:177–185
  7. Lee JH, Shin DH, Lupovitch A, et al.  Glycosylation of lens proteins in senile cataract and diabetes mellitus. Biochem Biophys Res Commun. 1984;123:888–893
  8. Brownlee M, Vlassara H, Cerami A. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. Ann Intern Med. 1984;101:527–537
  9. van Heyningen R. The sorbitol pathway in the lens. Exp Eye Res. 1962;1:396–404
  10. Unakar N, Tsui J, Johnson M. Aldose reductase inhibitors and prevention of galactose cataracts in rats. Invest Ophthalmol Vis Sci. 1989;30:1623–1632
  11. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res. 1974;19:577–582
  12. Perry RE, Swamy MS, Abraham EC. Progressive changes in lens crystallin glycation and high molecular weight aggregate formation leading to cataract development in streptozotocin diabetic rats. Exp Eye Res. 1987;44:269–282
  13. Chiou SH, Chylack LT, Bunn F, et al.  Role of nonenzymatic glycosylation to experimental cataract formation. Biochem Biophys Res Commun. 1980;95:895–901
  14. Szweregold BS, Kappler F, Brown TR. Identification of fructose 3-phosphate in the lens of diabetic rats. Science. 1990;247:451454
  15. Szwergold BS, Kappler F, Brown TR, et al.  Identification of d-sorbitol 3-phosphate in the normal and diabetic mammalian lens. J Biol Chem. 1989;264:9278–9282
  16. Gonzalez RG, Miglior S, Von Saltza I, et al.  31P NMR studies of the diabetic lens. Magn Reson Med. 1988;6:435–444
  17. Cheng HM, Xiong H, Xiong J, et al.  Metabolic studies of galactosemic cataract. Exp Eye Res. 1990;51:345–349
  18. Piras R. Synthesis of some aldose 2-phosphates. Arch Biochem Biophys. 1963;81:404–405
  19. Ball DH, Jones JKN. A synthesis of 3-O-β-galactopyranosyl-d-galactose. J Chem Soc. 1958;905–907
  20. Chittenden GJF, Roberts WK, Buchanan JG, et al.  The specific substance from pneumococcus type 34(41). In: the phosphomonoester linkages. ed 3. Biochem J. 109:1968;p. 597–602
  21. Kinoshita JH, Futterman S, Satoh K, et al.  Factors affecting the formation of sugar alcohols in ocular lens. Biochim Biophys Acta. 1963;74:340–350
  22. Cheng H-M, Xiong J, Tanaka G, et al.  Analysis of concurrent glucose consumption by the hexose monophosphate shunt, glycolysis, and the polyol pathway in the crystalline lens. Exp Eye Res. 1991;53:363–366
  23. Lal S, Szwergold BS, Kappler F, et al.  Detection of fructose-3-phosphokinase activity in intact mammalian lenses by 31P NMR spectroscopy. J Biol Chem. 1993;268:7763–7767
  24. Petersen A, Kappler F, Szwerdold BS, et al.  Fructose metabolism in the human erythrocyte. Biochem J. 1992;283:363–366
  25. Srivastava HK, Ansari NH, Hair GA, et al.  Hyperglycemia induced activation of human erythrocyte aldose reductase and alteration in kinetic properties. Biochim Biophys Acta. 1986;870:302–311

☆ Supported by National Institutes of Health Grants No. EY08414, DK44050, and CA41078, and the Commonwealth of Pennsylvania.

PII: 0026-0495(95)90069-1

Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1527-1531 , December 1995

Article Tools